Jonathan Chee

Crawley, WA, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Journal: Scientific reports
Published: November 03, 2025

Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8+ T cells in lymph nodes.

Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8+ T cells in lymph nodes.

Journal: Nature immunology
Published: February 16, 2025

Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients.

Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients.

Journal: Oxford open immunology
Published: December 10, 2024

Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade.

Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade.

Journal: Journal for immunotherapy of cancer
Published: September 08, 2024

Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes.

Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes.

Journal: Oncoimmunology
Published: April 30, 2024

Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma.

Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma.

Journal: Nature communications
Published: February 19, 2024

Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy.

Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy.

Journal: Cell reports. Medicine
Published: December 26, 2023

Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitor.

Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitor.

Journal: Clinical & translational immunology
Published: April 25, 2022

Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations.

Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations.

Journal: Frontiers in immunology
Published: February 09, 2022

CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy.

CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy.

Journal: Cell reports
Published: August 27, 2021

Interferons limit autoantigen-specific CD8+ T-cell expansion in the non-obese diabetic mouse.

Interferons limit autoantigen-specific CD8+ T-cell expansion in the non-obese diabetic mouse.

Journal: Cell reports
Published: August 22, 2021

Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies.

Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 21, 2021
Showing 1-12 of 38

Last Updated: 09/26/2026